156 related articles for article (PubMed ID: 33831661)
1. Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease.
Waggan I; Rissanen E; Tuisku J; Matilainen M; Helin S; Parkkola R; Rinne JO; Airas L
Parkinsonism Relat Disord; 2021 May; 86():40-44. PubMed ID: 33831661
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients.
Mishina M; Ishiwata K; Naganawa M; Kimura Y; Kitamura S; Suzuki M; Hashimoto M; Ishibashi K; Oda K; Sakata M; Hamamoto M; Kobayashi S; Katayama Y; Ishii K
PLoS One; 2011 Feb; 6(2):e17338. PubMed ID: 21386999
[TBL] [Abstract][Full Text] [Related]
3. Occupancy of adenosine A
Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
Neuropharmacology; 2018 Dec; 143():106-112. PubMed ID: 30253174
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A
Waggan I; Rissanen E; Tuisku J; Joutsa J; Helin S; Parkkola R; Rinne JO; Airas L
J Neurol; 2023 Jan; 270(1):300-310. PubMed ID: 36053386
[TBL] [Abstract][Full Text] [Related]
5. Chronic exposure to dopamine agonists affects the integrity of striatal D
Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
[TBL] [Abstract][Full Text] [Related]
6. Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease.
Ramlackhansingh AF; Bose SK; Ahmed I; Turkheimer FE; Pavese N; Brooks DJ
Neurology; 2011 May; 76(21):1811-6. PubMed ID: 21606452
[TBL] [Abstract][Full Text] [Related]
7. Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.
Rissanen E; Tuisku J; Luoto P; Arponen E; Johansson J; Oikonen V; Parkkola R; Airas L; Rinne JO
J Cereb Blood Flow Metab; 2015 Jan; 35(1):157-65. PubMed ID: 25370856
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET.
Mishina M; Ishiwata K; Kimura Y; Naganawa M; Oda K; Kobayashi S; Katayama Y; Ishii K
Synapse; 2007 Sep; 61(9):778-84. PubMed ID: 17568431
[TBL] [Abstract][Full Text] [Related]
9. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
11. Can adenosine A
Kanda T; Jenner P
Parkinsonism Relat Disord; 2020 Nov; 80 Suppl 1():S21-S27. PubMed ID: 33349576
[TBL] [Abstract][Full Text] [Related]
12. Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.
Jenner P
Expert Opin Investig Drugs; 2005 Jun; 14(6):729-38. PubMed ID: 16004599
[TBL] [Abstract][Full Text] [Related]
13. First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX.
Ishiwata K; Mishina M; Kimura Y; Oda K; Sasaki T; Ishii K
Synapse; 2005 Feb; 55(2):133-6. PubMed ID: 15543628
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of the Adenosine A
Schröder S; Lai TH; Toussaint M; Kranz M; Chovsepian A; Shang Q; Dukić-Stefanović S; Deuther-Conrad W; Teodoro R; Wenzel B; Moldovan RP; Pan-Montojo F; Brust P
Molecules; 2020 Apr; 25(7):. PubMed ID: 32252340
[TBL] [Abstract][Full Text] [Related]
15. [Adenosine receptor--relation to dopaminergic system].
Mishina M; Ishii K; Ishiwata K
Rinsho Shinkeigaku; 2007 Nov; 47(11):835-7. PubMed ID: 18210811
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A
Waggan I; Rissanen E; Tuisku J; Matilainen M; Parkkola R; Rinne JO; Airas L
Parkinsonism Relat Disord; 2023 Aug; 113():105766. PubMed ID: 37480614
[TBL] [Abstract][Full Text] [Related]
18. Imaging in Parkinson's disease: the role of monoamines in behavior.
Brooks DJ; Piccini P
Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
[TBL] [Abstract][Full Text] [Related]
19. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
[TBL] [Abstract][Full Text] [Related]
20. Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease.
Dietz M; Harder S; Graff J; Künig G; Vontobel P; Leenders KL; Baas H
Clin Pharmacol Ther; 2001 Jul; 70(1):33-41. PubMed ID: 11452242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
